Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy-Reference-Cited by-同舟云学术

Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy

Published:2020-03 Issue:3 Volume:271 Page:574-580
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Samiei Sanaz,van Nijnatten Thiemo J. A.,de Munck Linda,Keymeulen Kristien B. M. I.,Simons Janine M.,Kooreman Loes F. S.,Siesling Sabine,Lobbes Marc B. I.,Smidt Marjolein L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference22 articles.

1. Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer;Mamounas;Ann Surg Oncol,2015

2. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy;Schott;Breast Cancer Res Treat,2005

3. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol,1997

4. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy;Houssami;Eur J Cancer,2012

5. Pathological complete response in neoadjuvant treatment of breast cancer;Cortazar;Ann Surg Oncol,2015

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omission of Breast Surgery in Exceptional Responders;Clinical Breast Cancer;2024-06

2. The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer;BMC Cancer;2024-05-01

3. HER2-positive is an independent indicator for predicting pathological complete response to neoadjuvant therapy and Ki67-changed after neoadjuvant chemotherapy predicts favorable prognosis in Chinese women with locally advanced breast cancer;Medicine;2024-02-09

4. Assessment of the impact of residual tumors at different sites post-neoadjuvant chemotherapy on prognosis in breast cancer patients and development of a disease-free survival prediction model;Therapeutic Advances in Medical Oncology;2024-01

5. Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response;Journal of Breast Cancer;2024